Recent Quotes
My Watchlist
Indicators
Local Stocks
Buffalo Local Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY: JNJ )

168.50 USD +0.76 (+0.45%)
Official Closing Price Updated: 7:00 PM EDT, May 7, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about Johnson & Johnson

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
How Much Is BioNTech's Increased Vaccine Production Really Worth?
Additional capacity may not be as valuable as the initial doses. 
Tags MRNA JNJ AZN
From Motley Fool
Biotech ETFs To Suffer As US Backs IP Waiver For COVID-19 Vaccines
The Biden administration announced support for the waiver of intellectual property protections for COVID-19 vaccines proposed by South Africa and India. Let’s take a look at ETFs that can suffer from... 
Tags Stocks / Equities ETFs Market News
From Blogs - TalkMarkets
5 Cheap Growth Stocks For Q2 2021
After a brief selloff in Q1 2021, growth stocks are once again in focus. Investors can take advantage of this by investing in growth companies such as Johnson & Johnson, Target, Dell Technologies,... 
Tags Services Financial Technology
From Blogs - TalkMarkets
4 Reasons to Hang On to Your Moderna Stock
A proposal to nullify intellectual property regarding COVID-19 vaccines seems unlikely to affect Moderna's bottom line. 
Tags MRNA JNJ NVAX
From Motley Fool
Dow, S&P 500 both log new records despite weak April jobs report
The Dow Jones Industrial Average and the S&P 500 index on Friday both finish at new records on the same day for the first time in about three weeks while the Nasdaq outperformed as technology stocks... 
Tags AAPL SPX NQ00
From MarketWatch
Dow, S&P 500 both log new records despite weak April jobs report
The Dow Jones Industrial Average and the S&P 500 index on Friday both finish at new records on the same day for the first time in about three weeks while the Nasdaq outperformed as technology stocks... 
Tags BNTX JPM ES00
From MarketWatch
COVID-19 Vaccine Patent Polarizes The World: What You Need To Know
The COVID-19 pandemic is continuing to rage unabated. Just as countries across the globe were coming online from a protracted lockdown, ... 
Tags Benzinga MRNA vaccine
From Benzinga
Pfizer-BioNTech want full FDA approval for their vaccine — will a ‘yes’ improve vaccine hesitancy?
'This will be one less arrow in the concern quiver.' 
Tags BNTX PFE MRNA
From MarketWatch
EMA Safety Committee Reviews Heart Inflammation, Rare Nerve Disorder Reports After Pfizer, AstraZeneca COVID-19 Shots
European Medical Agency (EMA) isreviewing reportsof a rare nerve-degenerating disorder in people who ... 
Tags JNJ Government General
From Benzinga
Under-40s to be offered alternative COVID-19 vaccines to AstraZeneca’s
People under the age of 40 in the U.K. will be offered an alternative to the AstraZeneca COVID-19 vaccine, where possible, due to an "extremely small risk" from rare blood clots. 
Tags UK:AZN AZN BNTX
From MarketWatch
Big US Stocks’ Q1’21 Fundamentals
The red-hot US stock markets continue to power inexorably higher, fueling extraordinary complacency and euphoria. With stocks riding an extreme deluge of Fed money printing, selloffs are minor and far... 
Tags Stocks / Equities Market News
From Blogs - TalkMarkets
Under-40s to be offered alternative COVID-19 vaccines to AstraZeneca’s
People under the age of 40 in the U.K. will be offered an alternative to the AstraZeneca COVID-19 vaccine, where possible, due to an "extremely small risk" from rare blood clots. 
Tags MRNA JNJ BNTX
From MarketWatch
Four COVID-19 vaccines are being tested in children and teens. Here’s when to expect a shot for different age groups
The Food and Drug Administration is expected to grant emergency authorization to Pfizer's COVID-19 vaccine for 12 to 15-year-olds within the week. If that occurs, it will be the first shot authorized... 
Tags PFE BNTX JNJ
From MarketWatch
Four COVID-19 vaccines are being tested in children and teens. Here’s when different age groups could become eligible for shots.
The Food and Drug Administration is expected to grant emergency authorization to Pfizer's COVID-19 vaccine for 12- to 15-year-olds within the week. If that occurs, it will be the first shot authorized... 
Tags MRNA NVAX JNJ
From MarketWatch
Four COVID-19 vaccines are being tested in children and teens. Here’s when to expect a shot for different age groups
The Food and Drug Administration is expected to grant emergency authorization to Pfizer's COVID-19 vaccine for 12 to 15-year-olds within the week. If that occurs, it will be the first shot authorized... 
Tags JNJ NVAX MRNA
From MarketWatch
Notable ETF Outflow Detected - IVE, BAC, JNJ, PM
Symbols mentioned in this story: IVE, BAC, JNJ, PM Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''... 
Tags ETFs
From ETF Channel
Dow aims for longest win streak since March ahead of April jobs report
The Dow Jones Industrial Average is set to add to its record ride Friday, as investors brace for a report on conditions in the U.S. labor market as the economy recovers from COVID pandemic. 
Tags YMM21 SPX DJIA
From MarketWatch
Under-40s to be offered alternative COVID-19 vaccines to AstraZeneca in U.K.: reports
People under the age of 40 in the U.K. will be offered an alternative to the AstraZeneca COVID-19 vaccine as a precautionary measure, following concerns of rare blood clots linked to the shot, several... 
Tags MRNA JNJ UK:AZN
From MarketWatch
Does Ocugen Have a Real Shot at the U.S. COVID Vaccine Market?
The biotech faces some big challenges. 
Tags OCGN MRNA JNJ
From Motley Fool
Here Are the Best Healthcare Stocks That Robinhood Investors Love
There are some well-known and not-so-well-known names on the list. 
Tags JNJ TNXP MRNA
From Motley Fool
Can you be fired for refusing to get a COVID-19 vaccine? America is about to find out
A court date on an early test is coming up later in May, and that's just one of several lawsuits making their way through the system. 
Tags MRNA JNJ BNTX
From MarketWatch
5 Cheap Growth Stocks for Q2 2021
InvestorPlace - Stock Market News, Stock Advice & Trading Tips After a brief selloff in Q1 2021, growth stocks are once again in focus. Investors can take advantage of this by investing in growth... 
Tags TGT GS JNJ
From InvestorPlace
Will corporate greed prolong the COVID-19 pandemic?
Joseph Stiglitz and Lori Wallach debunk Big Pharma's big lies about why they can't share lifesaving technologies by agreeing to temporary waivers on patent rights 
Tags PFE AZN BNTX
From MarketWatch
Want to Buy a Micro-Concert from Lady Gaga? That Might be Coming Soon as an NFT
Photo credit If a picture is said to be worth a thousand words, is a digital picture with animation and audio capabilities worth a ... 
Tags NexTech AR Solutions DELL Markets
From Benzinga
Biden’s move on vaccine patents represents blow for the second-biggest spender on Washington lobbying
The Biden administration’s Wednesday decision to support waiving intellectual-property protections for COVID-19 vaccines counts as a significant disappointment for drugmakers, who rank among the... 
Tags JNJ MRNA SPX
From MarketWatch
7 Safe Stocks You Can Leave to Your Children
InvestorPlace - Stock Market News, Stock Advice & Trading Tips While it’s easy to get carried away with the speculation, investors should consider these safe stocks to hand down to their progeny. The... 
Tags NYSE:MCD,NYSE:ADM,NYSE:JNJ,NASDAQ:MSFT,NYSE:DIS,NYSE:PG,NYSE:CSV MSFT JNJ
From InvestorPlace
What Will the Stock Market Do Today? 3 Big Stories to Watch.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips So what will the stock market do today? Investors are closely watching Covid-19 vaccine makers like OCGN stock this morning. The post What... 
Tags IBM MRNA PFE
From InvestorPlace
Biden Administration Backs Waiving IP Protections For COVID-19 Vaccines, Pharma Industry Rebukes Move
The closely watched issue of patent rights for COVID-19 vaccines garnered headlines again as the Biden administration came out in ... 
Tags Biotech Regulations BNTX
From Benzinga
The Biggest Loser With Johnson & Johnson's COVID Vaccine Manufacturing Woes
It's obvious. 
Tags EBS Market News JNJ
From Motley Fool
Is It Too Late to Buy Johnson & Johnson Stock?
Here's why you haven't missed the boat on this blue chip. 
Tags MRNA Market News JNJ
From Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.